SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-18-000361
Filing Date
2018-10-26
Accepted
2018-10-26 13:29:43
Documents
79
Period of Report
2018-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K gnbt073018form10k.htm 10-K 1809875
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 18463
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 18185
4 EXHIBIT 32 ex32.htm EX-32 6853
11 GRAPHIC image_001.gif GRAPHIC 12272
  Complete submission text file 0001607062-18-000361.txt   5154167

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20180731.xml EX-101.INS 609082
6 XBRL SCHEMA FILE gnbt-20180731.xsd EX-101.SCH 53754
7 XBRL CALCULATION FILE gnbt-20180731_cal.xml EX-101.CAL 38994
8 XBRL DEFINITION FILE gnbt-20180731_def.xml EX-101.DEF 190868
9 XBRL LABEL FILE gnbt-20180731_lab.xml EX-101.LAB 326206
10 XBRL PRESENTATION FILE gnbt-20180731_pre.xml EX-101.PRE 288681
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 181141206
SIC: 2834 Pharmaceutical Preparations